^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

JRF104

i
Other names: JRF104
News
Trials
Company:
Jinrui Foundation, WuXi AppTec
Drug class:
FLT3 inhibitor, AXL inhibitor
Related drugs:
News
Trials